We are live on ! Find out more
RNS

Robert N. Shapiro Portfolio holdings

AUM $501M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+2.15%
1 Year Est. Return
+11.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$541M
AUM Growth
-$17.6M
Cap. Flow
-$26.8M
Cap. Flow %
-4.95%
Top 10 Hldgs %
21.64%
Holding
811
New
50
Increased
118
Reduced
280
Closed
41

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$1.85M
2
COST icon
Costco
COST
+$1.77M
3
MCO icon
Moody's
MCO
+$1.34M
4
PFE icon
Pfizer
PFE
+$1.2M
5
UNH icon
UnitedHealth
UNH
+$1.19M

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$4.38M
2
ORCL icon
Oracle
ORCL
+$2.06M
3
EMC
EMC CORPORATION
EMC
+$2.06M
4
IBM icon
IBM
IBM
+$1.58M
5
NVS icon
Novartis
NVS
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 14.91%
2 Technology 13.53%
3 Industrials 12.31%
4 Energy 11.97%
5 Financials 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
76
Biogen
BIIB
$29.6B
$2.11M 0.39%
6,893
-185
-3% -$58.7K
DHR icon
77
Danaher
DHR
$135B
$2.11M 0.39%
41,795
-3,804
-8% -$194K
BP icon
78
BP
BP
$113B
$2.1M 0.39%
53,522
-861
-2% -$34K
BUD icon
79
AB InBev
BUD
$155B
$2.09M 0.39%
19,839
+7,076
+55% +$718K
ABT icon
80
Abbott
ABT
$175B
$2.08M 0.38%
54,051
-7,170
-12% -$276K
EL icon
81
Estee Lauder
EL
$28.9B
$2.02M 0.37%
30,245
+5,943
+24% +$413K
COST icon
82
Costco
COST
$411B
$1.99M 0.37%
17,832
+15,478
+658% +$1.77M
PX
83
DELISTED
Praxair Inc
PX
$1.98M 0.37%
15,135
-877
-5% -$114K
NVS icon
84
Novartis
NVS
$297B
$1.96M 0.36%
25,689
-21,366
-45% -$1.56M
QCOM icon
85
Qualcomm
QCOM
$180B
$1.93M 0.36%
24,464
-210
-0.9% -$15.8K
XBI icon
86
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$1.91M 0.35%
40,200
-2,775
-6% -$142K
FTI icon
87
TechnipFMC
FTI
$30.3B
$1.88M 0.35%
48,282
-3,781
-7% -$143K
AMGN icon
88
Amgen
AMGN
$201B
$1.87M 0.35%
15,182
-308
-2% -$37.4K
CVS icon
89
CVS Health
CVS
$136B
$1.84M 0.34%
24,607
+975
+4% +$68.9K
TEL icon
90
TE Connectivity
TEL
$57.6B
$1.83M 0.34%
30,370
-2,285
-7% -$131K
COR icon
91
Cencora
COR
$59.4B
$1.83M 0.34%
27,845
-1,475
-5% -$100K
CME icon
92
CME Group
CME
$91.9B
$1.81M 0.33%
+24,466
New +$1.85M
TYC
93
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$1.8M 0.33%
40,659
-2,793
-6% -$122K
PBI icon
94
Pitney Bowes
PBI
$2.42B
$1.8M 0.33%
69,177
+11,213
+19% +$277K
TOL icon
95
Toll Brothers
TOL
$13.7B
$1.79M 0.33%
49,914
-3,168
-6% -$117K
CTAS icon
96
Cintas
CTAS
$81.3B
$1.78M 0.33%
119,428
-6,600
-5% -$97.5K
PCP
97
DELISTED
PRECISION CASTPARTS CORP
PCP
$1.76M 0.33%
6,967
-591
-8% -$153K
PCAR icon
98
PACCAR
PCAR
$68.8B
$1.75M 0.32%
38,910
-2,385
-6% -$98.3K
GNRC icon
99
Generac Holdings
GNRC
$12.4B
$1.73M 0.32%
29,345
-1,342
-4% -$73.4K
GSK icon
100
GSK
GSK
$102B
$1.73M 0.32%
25,810
-1,179
-4% -$79.7K

Similar funds

Robert N. Shapiro's Q1 2014 Portfolio in Review

As of Q1 2014, Robert N. Shapiro held 811 positions worth $541M, down 3.1% from $559M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Robert N. Shapiro withdrew a net $26.8M in Q1 2014, closing 41 positions and reducing 280 holdings. Its most notable exit was Conagra Brands, an estimated $162K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

Against the trend, Robert N. Shapiro opened a new position in CME Group worth $1.81M.

  • Robert N. Shapiro's largest Q1 2014 buy was CME Group: 24,466 shares worth $1.81M.
  • Robert N. Shapiro added most to Costco in Q1 2014, an estimated $1.77M increase.
  • Robert N. Shapiro's biggest Q1 2014 reduction was SPDR Gold Trust, cutting an estimated $4.38M.
  • Robert N. Shapiro fully exited Conagra Brands in Q1 2014, selling an estimated $162K.
  • Robert N. Shapiro's ten largest holdings make up 22% of its $541M portfolio in Q1 2014.
  • Robert N. Shapiro opened 50 new positions and closed 41 in Q1 2014.
  • Robert N. Shapiro's portfolio value fell 3.1% quarter-over-quarter to $541M.

Based on Robert N. Shapiro's 13F filing for Q1 2014, filed 18 Jun 2014.